Calculate Your Salary Ranking
Home > Pain Therapeutics Salary

Pain Therapeutics Salary
  • 52
  • 13
  • 66

Pain Therapeutics average salary is $140,000, median salary is $140,000 with a salary range from $140,000 to $140,000.
Pain Therapeutics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Pain Therapeutics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 1 Pain Therapeutics Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
Director - Quality Control 140,000-140,000 San Mateo, CA, 94401 2010 Pain Therapeutics Director - Quality Control Salaries (1)
Pain Therapeutics San Mateo, CA Salaries
Pain Therapeutics Jobs
See more Pain Thera Jobs »
  • Manufacturing Technician
    Product lines include rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments,...
  • NURSE, STAFF - Newborn ICU
    — no needless death, injury, pain or suffering for patients or staff. A) Provides and maintains a therapeutic environment for patients and families....
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent Pain Therapeutics Salaries (February 26, 2017)
Assistant Professor University of Oklahoma $42,860 Norman, OK, 73019 01/05/2015
General OMRON $65,998 Houston, TX, 77001 09/07/2015

Pain Therapeutics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Pain Therapeutics Information
  • Pain Therapeutics Inc
  • Industry: Other
  • City: San Mateo, CA
  • Pain Therapeutics, Inc. is a biopharmaceutical company that develops drugs. As of December 31, 2008, the Company had four drug candidates in clinical programs, including Remoxy, PTI-202, PTI-721 and a radio-labeled monoclonal antibody to treat metastatic melanoma. The Company is also working on a new treatment for patients with hemophilia. PTI-202 and PTI-721 are abuse-deterrent forms of opioid drugs. The Company and King Pharmaceuticals, Inc. (King) are engaged in a strategic alliance to develop and commercialize Remoxy, PTI-202, PTI-721 and other abuse-resistant opioid painkillers.(Source: 10-K)